Verification test of blood glucose level fluctuation by intake of test food

Not Applicable

• Conditions: /A

• Registration Number: JPRN-UMIN000050450
• Lead Sponsor: Morinaga & Co., Ltd.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2023-03-17
• Study Start: 2023-06-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Not provided

Exclusion Criteria

1) Individuals using medical products. 2) Individuals who used a drug for treatment of disease in the past 1 month. 3) Individuals who have a history of serious hepatopathy, kidney damage, heart disease, hematological and blood disease. 4) Individuals who contract or have a history of serious gastrointestinal disease. 5) Individuals with serious anemia. 6) Individuals who contract or have a history of food allergy. (milk, gelatin) 7) Females who are or are possibly pregnant, or are lactating. 8) Individuals who have an addiction to alcohol or a mental illness. 9) Individuals who are a smoker. 10) Individuals with high blood glucose (fasting blood glucose over 110 mg/dL). 11) Individuals whose life style will change during the test period. 12) Individuals with probable seasonal allergy, such as pollinosis, during the test period.(Betulaceae: alder, oba alnus firma, shirakaba, Taxodiaceae: cryptomeria, hinoki cypress, Asteraceae: ragweed, Artemisia vulgaris indica, Gramineae:Dactylis glomerata, Phleum pratense) 13) )Individuals who had a habit to ingest foods claiming to effect on blood glucose level improvement , foods for specified health uses, health foods, or supplements in the past 3 months or will ingest those foods during the test period. 14) Individuals who have a habit to use drug claiming to effect on blood glucose level improvement in the past 3 months. 15) Individuals who conducted hormone replacement therapy in the past 6 months or have a history of conducting hormone replacement therapy. 16) Individuals who were hospitalized and received treatment in the past 6 months, or will be hospitalized during the test period. 17) Individuals who participated in other clinical studies in the past 1 months. 18) Individuals judged inappropriate for the study by the principal.

Study & Design

• Study Type: Interventional
• Study Design: Not specified